Due to recent economic downturns, many small businesses are finding it more difficult to obtain funding from traditional lending sources. Tight credit conditions and limited profit margins can leave many smaller enterprises with serious cash flow management difficulties.

Why is financing such a problem for today’s small and medium-sized enterprises (SMEs)? After all, hasn’t the Federal Reserve reduced the costs of borrowing money for businesses through its quantitative easing measures?

The cost of pharmaceutical innovation can be a limiting factor in the creation of new drugs and treatments for a variety of illnesses. Research and development can be an expensive undertaking, especially for smaller firms working to synthesize only one or two new drugs for the medical marketplace.

Manufacturing companies depend upon reliable supply chains and distribution companies to ensure that materials are available for production activities and to get their products to market in a timely way.